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Expression of the human foamy virusbel-l 
transactivator in insect cells 
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The human foamy virus (HFV) bel-l transactivator protein was expressed in 
insect cells by a recombinant baculovirus. For the generation of the recombinant 
baculovirus, Acbel-1, the bel-l gene of an HFV mutant was used, that bears 
truncations in the bel-l overlapping bel-2 open reading frame. Acbel-1 infected Sf9 
cells produced high amounts of recombinant protein of the same electrophoretic 
mobility (36 kD) as bel-l expressed in mammalian cells. The baculovirus expressed 
bel-l proteinwas readily identified by a polyclonal rabbit serum directed against 
bel-l in immunoblot assay. As in mammalian cells, bel-l was predominantly 
localized to the nucleus of Acbel-1 infected insect cells. The baculovirus expressed 
bel-l proteinwill be of use to determine the action of this novel viral transactivator 
more precisely. 
Human foamy virus bel-l transactivator; Expression in insect cells 
Human foamy virus (HFV) is a member of the foamy virus subgroup of 
exogenaus retroviruses (Teich, 1982). Foamy viruses have been isolated from Old 
and New World primates, felines, bovines and occasionally from man (Flügel, 
1991). They replicate in a wide range of tissue culture cells giving rise to intensively 
vacuolated ('foamy') multinucleated syncytia (Hooks and Detrick-Hooks, 1981). In 
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their natural hosts they cause persistent infections and have been isolated from 
many different tissues (Hooks and Detrick-Hooks, 1981). Apart from the 
pathogenicity of HFV when introduced into the germ line of mice (Bothe et al., 
1991), foamy viruses have never been convincingly associated with any disease 
(Weiss, 1988). 
HFV has been molecularly cloned, sequenced, and full length infectious molec-
ular plasmids have been constructed from subgenomic clones (Rethwilm ·et al., 
1987, 1991; Flügel et al., 1987; Maurer et al., 1988; Lächelt et al., 1991). Nu-
cleotide sequence analysis of HFV revealed three open reading frames (ORFs) in 
addition to the structural genes gag, pol, and env, which are located in the 3' 
region of the viral genome and have been named bei (Flügel et al., 1987; Flügel, 
1991). Accessory ORFs have also been discovered in the related simian foamy 
viruses 1 and 3 (SFV 1 and 3) (Mergia et al., 1991; Kupiec et al., 1991; Renne et 
al., 1992). In HFV it has been shown recently that beside the structural genes gag, 
pol, and env only the first of the accessory ORFs, bel-l, is required for replication 
in vitro (Baunach et al., 1993). 
The bel-l gene, and the respective genes of SFV-1 and 3, encode for a 
transactivator of viral long terminal repeat (LTR) directed transcription (Rethwilm 
et al., 1991; Mergia et al., 1991; Renne et al., 1993). While the dissection of bel-l 
into functional domains has led to a controversial interpretation of the results 
(Venkatesh et al., 1993; He et al., 1993), it is principally agreed that bel-l is an 
approximately 36 kD nuclear phosphoprotein that acts on a DNA (U3) element of 
the LTR to augmentviral transcription (Rethwilm et al., 1991; Keller et al., 1991; 
Venkatesh et al., 1991, 1993). The target sequence for bel-l has been mapped to a 
region spanning from - 471 to - 93 relative to the start of transcription (Erlwein 
and Rethwilm, 1993). Furthermore, it has been shown that distinct fragments of 
this region are sufficient to respond to bel-l (Lee et al., 1993; Erlwein and 
Rethwilm, 1993). However, the precise mechanism of bel-l transactivation remains 
unknown. In particular, experiments to demoostrate direct binding of prokaryoti-
cally expressed bel-l to its target sequences· in the LTR have been unsuccessful 
(Venkatesh et al., 1993; Erlwein and Rethwilm, 1993). We therefore aimed to 
express bel-l in the baculovirus system to produce a recombinant protein as a 
source for future sturlies on the action of this novel viral transactivator. 
The cloning strategy for the generation of the bel-l transfer plasmid is shown in 
Fig. 1. Briefly, a 1.05 kb Sspl fragment covering the complete bel-l coding 
sequence was excised from pHSRV-M6 (Baunach et al., 1993), Iigated to Bglll 
linkers and inserted into the BamHI site of the baculovirus transfer vector 
pAcYMl (Matsuura et al., 1987). pHSRV-M6 is an infectious HFV plasmid with a 
functional bel-l gene and two stop codons introduced into the bel-l overlapping 
bel-2 ÖRF by in vitro mutagenesis (Baunach et al., 1993). The resulting plasmid, 
pAcbel-1, was used to generate recombinant bel-l expressing baculovirus by 
cotransfection with AcRP23-lacZ virus DNA (Possee and Howard, 1987) into 
Spodoptera frugiperda (Sf9) cells. Selection of recombinants, plaque purification, 
and preparation of virus stocks was done according to established methods 
(Matsuura et al., 1987; Possee and Howard, 1987). 
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Fig. 1. Cloning strategy for the generation of pAcbel-1. Bglll linkers were added to the Sspl fragrnent 
of pHSRV mutant M6 (Baunach et al., 1993) which comprises the complete bel-l gene of HFV. After 
cleavage with Bglll the 1.05 kb fragment was inserted into the BamHI cloning site . of pAcYMl 
(Matsuura et al., 1987) downstream of the polyhedrin promoter (Phd-P). M6 bears two stop codons 
introduced into the bel-l overlapping bel-2 ORF by in vitro mutagenesis. The mutations leave the bei-~ 
gene unaffected but truncate the putative bel-2 protein and a proteinthat is derived from an mRNA 
~hat is spliced from the bel-l ORF (SD) into the bel-2 OR.F (SA) (Baunach et al., 1993). 
lnsect cells infected with the recombinant baculovirus, Acbel-1, were character-
ized by Coomassie blue staining of proteins in infected cell extracts separated by 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and by immunological meth-
ods using a polyclonal rabbit serum generated against prokaryotically expressed 
bel-l (Aguzzi et al., 1993). As shown in Fig. 2A, a protein with an approximate 
molecular weight of 36 kD was stained in extracts of Acbel-1 infected cells 
harvested 24 h after infection. Such a protein was not detected in lysates from 
uninfected or AcNPV infected Sf9 cells. Comparison with a bovine serum albumin 
standard (not shown) indicated that 1 X 108 Sf9 cells infected with Acbel-1 at an 
m.o.i. of 10 produce 0.1-0.2 mg bel-l protein after 48 h. Western blot analysis 
revealed the 36 kD protein to be specifically stained with the bel-l antiserum (Fig. 
2B). No bel-l reactive protein was detected in the lanes containing lysates from 
uninfected cells or cells infected with the control virus. The novel Acbel-1 encoded 
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Fig. 2. (A) Coomassie blue stained SDS·lO% PAGE of lysates from uninfected, AcNPV infected and 
St9 cells which were infected with Acbel-1 for 24, 48, and 72 h, respectively. In the lane with lysate from 
AcNPV infected cells the appro:ximately 29 kD polybedrin protein is detected as a prominent band, 
while in Acbel·l infected cell lysates a novel protein with an approximate molecular weight of 36 kD 
appeared. The production of the recombinant protein was maximal after 48 h of infection of Sf9 cells 
with an m.o.i. of 10. The methods of preparation of cell extracts and SOS-PAGE were as described 
previously (Bräutigam et al., 1993). (8) Immunoblot of Acbel-1 infected Sf9 cells with rabbit anti-bel-l 
directed serum. Cellular extracts were prepared from 8 x 104 St9 cells either uninfected, infected with 
AcNPV, infected with Acbel-1 at an m.o.i of 10 for 24, 48, and 72 h, respectively, and from 1 x 106 3T3 
cells stably produclog bel-l protein (Retbwilm et al., 1993). Proteins were resolved on SDS-10% PAGE 
and semi-dry blotted onto nitrocellulose filter (Schleicher and Schüll). Immune reaction with rabbit 
serum diluted 1 : 500 followed by washing, incubation with peroxidase coupled goat anti-rabbit lgG 
(Dako), and visualization of bands using the ECL chemiluminescence detection system (Amersham) 
were performed as described (Baunach et al., 1993). The 36 kD bel-l proteinwas detected in lysates 
from 3T3 /bel-l cells and from Sf9 cells infected with Acbel-1. Due to tbe intensifying capacity of the 
ECL detection system used, other bel-l antibody reactive proteins smaller than 36 kD were also 
detected in lysates from Sf9 cells infected with Acbel-1. These proteins may represent degradation 
products of bel-l. 
proteinwas of the same electrophoretic mobility in SDS-PAGE as a bel-l anti-
serum reactive protein in extracts from NIH 3T3 cells which were stably trans-
fected with a bel-l expressing retroviral vector (Rethwilm et al., 1993), indicating 
that the novel protein is indeed bel-l. The time course of bel-l expression in Sf9 
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cells revealed that bel-l was readily detectable in cells infected for 24 h. The 
production of recombinant protein was maximal after 48 h. Other bel-l reactive 
proteins smaller than 36 kD were also detected which might represent degradation 
products of bel-l. 
Bel-l is a nuclear protein when expressed in mammalian cells (Keller et al., 
1991). The nuclear localization signal has been mapped to a basic stretch of amino 
acids between positions 211 and 225 (Venkatesh et al., 1993; He et al., 1993). To 
determine whether the expressed bel-l was transported to the nucleus, Acbel-1 
infected Sf9 cells were analyzed by indirect immunofluorescence (IF A). A nuclear 
fluorescence was readily observed in recombinant infected cells (Fig. 3A) indicat-
ing that the nuclear localization signal was also active in insect cells. No im-
munofluorescence was seen in cells infected with AcNPV (Fig. 3B) or in unin-
Fig. 3. Immunofluorescence of recombinant baculovirus infected cells. Infected Sf9 cells were incubated 
with polyclonal rabbit serum directed against bel-l followed by fluorescein-conjugated second antibody 
from goat. IFA was performed as described (Prehaud et al., 1989) with 1:500 diluted first and 1:1000 
diluted second antibody. Total immunofluorescence was done using acetone fixed, permeabilized cells 
(A, B). Surface immunofluorescence was examined by using non-fixed cells (C). (A) Recombinant 
Acbel-1 infected cells, total immunofluorescence; (B) AcNPV wild type baculovirus infected cells, total 
immunofluorescence; (C) Acbel-1 infected cells, surface immunofluorescence. 
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fected Sf9 cells (not shown). To support specifically intracellular localization of 
bel-l indirect immunofluorescence antibody staining was done on cells without 
fixation and permeabilization (Fig. 3C). No surface or background fluorescence on 
Acbel-1 infected cells was observed. 
The .baculovirus expression system has been used extensively for the expression 
of proteins regulating the expression of viral and non-viral genes (for review see 
Luckow and Summers, 1988; Bishop, 1992). The recombinant bel-l protein de-
scribed in this study may be of use in determining the, as yet, unclear mechanism 
of action of this novel viral transactivator protein in a more precise manner than 
with the prokaryotically expressed bel-l that has been used in previous studies 
(Venkatesh et al., 1993; Erlwein and Rethwilm, 1993). 
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